About this trial
This study compares ketamine/fentanyl versus ketamine/lidocaine in term of their impact on cerebral perfusion during CABG. No prior data address these effects, and the goal is to identify the induction regimen that better preserves cerebral oxygenation.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patients with coronary artery disease
with moderate to severe left ventricular dysfunction (ejection fraction < 40%),
scheduled for elective CABG surgery
Disqualifiers
associated chronic stroke, TIA , carotid occlusive disease( due to abnormal vasomotor activity), patients with known neurological impairment (cerebral infarction , dementia ), significant carotid artery stenosis ,
valvular heart disease,
persistent arrhythmias,
congestive cardiac failure,
Trial design
Parallel
Treatments tested in this trial
Fentanyl (IV)
Drugpatients will receive 1 mcg/kg of Fentanyl (10 mcg/mL).
lidocaine
Drugpatients will receive 1 mg/kg lidocaine (10mg/mL)
Treatment groups
Trial outcomes
Primary outcomes
average postinduction NIRS
average values of NIRS reading after induction of anesthesia
Secondary outcomes
mean arterial pressure
invasive mean arterial pressure
heart rate
bpm
NRIS
average of left and right side reading
cerebral hypoperfusion
NIRS\<60% or \<90% of baseline reading
Other outcomes
vasopressor dose
Sponsors and contacts
Click on the lead sponsor to view all of their trials.